Enveric Biosciences, Inc. Temporary Equity, Accretion to Redemption Value
Financial Statements › Shareholders' Equity
us-gaap:TemporaryEquityAccretionToRedemptionValue · last filed 2025-03-28
- Enveric Biosciences, Inc. temporary equity, accretion to redemption value for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- Enveric Biosciences, Inc. temporary equity, accretion to redemption value for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- Enveric Biosciences, Inc. temporary equity, accretion to redemption value for the quarter ending 2023-06-30 was $37.00K.
- Enveric Biosciences, Inc. temporary equity, accretion to redemption value for the quarter ending 2023-03-31 was $110.99K.
- Enveric Biosciences, Inc. temporary equity, accretion to redemption value for fiscal 2023 was $147.99K, a 50.00% decline from fiscal 2022.
- Enveric Biosciences, Inc. temporary equity, accretion to redemption value for fiscal 2022 was $295.98K.
| Period end | Temporary Equity, Accretion to Redemption Value 3 month | Temporary Equity, Accretion to Redemption Value 6 month | Temporary Equity, Accretion to Redemption Value 9 month | Temporary Equity, Accretion to Redemption Value 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $0.00 derived: sum of 2 quarters · filed 2025-03-28 | $37.00K derived: sum of 3 quarters · filed 2025-03-28 | $147.99K 10-K · filed 2025-03-28 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $37.00K derived: sum of 2 quarters · filed 2023-11-13 | $147.99K 10-Q · filed 2023-11-13 | $258.98K derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $147.99K 10-Q · filed 2023-08-11 | $258.98K derived: sum of 3 quarters · filed 2023-08-11 | $369.97K derived: sum of 4 quarters · filed 2023-08-11 |
| 2023-03-31 | $110.99K 10-Q · filed 2023-05-15 | $221.98K derived: sum of 2 quarters · filed 2023-06-09 | $332.97K derived: sum of 3 quarters · filed 2023-06-09 | |
| 2022-12-31 | $110.99K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-09 | $221.98K derived: sum of 2 quarters · filed 2023-06-09 | $295.98K 10-K/A · filed 2023-06-09 | |
| 2022-09-30 | $110.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $184.99K 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | $73.99K 10-Q · filed 2022-08-12 |